Elisa Perez-Bernat, M ª Angeles Viñas, Manel Vera, Miguel González-Rico, Marco Montomoli, Elena Astudillo-Cortés, Juan Carlos Quevedo-Reina, Isabel García-Méndez, Adoración Martinez-Losa, Ines Rama-Arias, María Maldonado-Martín, M ª Antonia Munar, Agustín Ortega Cerrato, Sandra Beltrán-Catalán, Gloria Del Peso, Aleix Cases, Jose Luis Górriz
Atrial fibrillation is the most frequent chronic arrhythmia in patients with chronic kidney disease. Oral anticoagulation with vitamin K antagonists and now direct oral anticoagulants have been and are the fundamental pillars for the prevention of thromboembolic events. However, there are no randomized clinical trials on the risk-benefit profile of oral anticoagulation in patients with chronic kidney disease stage 5 on peritoneal dialysis and there is little evidence in the literature in this population. The objective of our study was to know the prevalence, treatment and professionals involved in the management of atrial fibrillation in peritoneal dialysis patients...
April 11, 2024: Nefrología